AOA

Scaffold Therapeutics, based in Boston, MA, is pioneering a unique drug discovery platform focused on RNA biology, targeting clinically validated and first-in-class biology in oncology, neurodegeneration, and other therapeutic areas. The company's research emphasizes the regulation of RNA modifications that influence its stability, transcription, and degradation. Recently, Scaffold Therapeutics has partnered with QureALZ, a company dedicated to advancing research on Alzheimer's and other neurodegenerative disorders. This collaboration aims to leverage Scaffold's drug discovery platform and expertise to explore treatments for a variety of diseases, including Alzheimer's, ALS, and brain cancer. Generated from the website

At The Live Green Co, they use technology to make plant-based foods tastier, healthier & more sustainable. The recommendation engine blends ancestral wisdom of plant nutrition with Biotech & AI-ML, profiles the synthetic, ultra-processed & animal additives in food products, and prescribes 100% natural plant-only ingredient replacements & formulations at just a fraction of the R&D cost & time. It is no more about a few people following a sustainable lifestyle perfectly. It is about millions doing it, even if imperfectly.

Niviron was founded in 2021. The company is based in Boston, Massachusetts, USA. The main goal of the company is to extend the humanlife span by advancement new technologies aimed at the treatment of oncological diseases. The company focuses on research in the field of cancer therapy with oncolytic viruses. Our attention is focused on the main approaches of viral cancer therapy: 1. Activation and targeting of the tumor by the immune system; 2. Destruction of cancer cells directly by an oncolytic virus; 3. Impact on the tumor microenvironment.